Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Jorgensen JM et al. – The aim of the study was to investigate the expression of angio– and lymphangiogenic molecules (vascular endothelial growth factors VEGF and VEGF–C and their receptors Flt–1, KDR, and Flt–4) in non–Hodgkin lymphomas (NHL) treated in the pre–rituximab era. In PTCL, diffuse tissue distribution of VEGF mRNA correlated with an unfavorable 5–year OS.



Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address